Outside Review of Clinical Data Finds a Spinal Treatment’s Benefit Overstated


Independent reviews of clinical trial data concluded that Infuse, a bioengineered bone product, was not significantly better than a traditional bone graft, and that it might pose risks.

Sent by gReader Pro


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s